Merit Medical Systems, Inc.

MMSI Healthcare Medical Instruments & Supplies

Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 9.51%, EPS grew 18.2%, free cash flow fell 25.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

89.20 0.37 −0.41%
Market cap
$5.4B
P/E
36.4×
Fwd P/E
23.4×
Dividend yield
—
F-score
7/9
Altman Z
4.42
Beneish M
−2.70
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

41.41 40.62 29.33 28.30
P/S ratio
3.34 3.44 2.66 2.62
P/FCF ratio
24.19 24.53 18.87 20.72
P/Operating CF
65.76 52.93 100.83 59.73
P/B ratio
3.22 3.29 2.52 2.46
EV/Sales
3.57 3.63 2.82 2.81
EV/EBITDA
17.27 16.94 13.23 12.92
EV/FCF
25.88 25.90 20.02 22.17
Current Ratio
4.28 4.34 5.08 4.20
Net Debt/EBITDA
4.35 3.20 3.13 3.00
Debt/Equity
0.48 0.46 0.45 0.44
Earnings Yield
2.41% 2.46% 3.41% 3.53%
Free Cash Flow Yield
4.13% 4.08% 5.30% 4.83%
Free Cash Flow per Share
0.87 1.24 0.40 0.86
Book value per Share
25.82 26.78 27.34 28.15
Free Cash Flow
51.56 73.20 23.92 51.09
EV/EBIT
31.57 29.80 23.17 22.00
Other line items

Show all line items

Columns are period end dates